A Novel TP53 Mutation Associated with TWIST1 and SIP1 Expression in an Aggressive Adrenocortical Carcinoma-Reference-Cited by-同舟云学术

A Novel TP53 Mutation Associated with TWIST1 and SIP1 Expression in an Aggressive Adrenocortical Carcinoma

Published:2017-04-18 Issue:4 Volume:28 Page:326-331
ISSN:1046-3976
Container-title:Endocrine Pathology
language:en
Short-container-title:Endocr Pathol

Author:

Bulzico Daniel^ORCID,Torres Davi Coe,Ferreira Gerson Moura,Pires Bruno Ricardo Barreto,de Faria Paulo Antônio Silvestre,Hassan Rocio,Abdelhay Eliana,Vaisman Mario,Vieira Neto Leonardo

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s12022-017-9482-7/fulltext.html

Reference40 articles.

1. Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A (2006) Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 30 (5):872–878.

2. Fassnacht M, Kroiss M, Allolio B (2013) Update in adrenocortical carcinoma. J Clin Endocrinol Metab 98 (12):4551–4564.

3. Wasserman JD, Novokmet A, Eichler-Jonsson C, Ribeiro RC, Rodriguez-Galindo C, Zambetti GP, Malkin D (2015) Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children’s oncology group study. J Clin Oncol 33 (6):602–609.

4. Herrmann LJ, Heinze B, Fassnacht M, Willenberg HS, Quinkler M, Reisch N, Zink M, Allolio B, Hahner S (2012) TP53 germline mutations in adult patients with adrenocortical carcinoma. J Clin Endocrinol Metab 97 (3):E476–E485.

5. Raymond VM, Else T, Everett JN, Long JM, Gruber SB, Hammer GD (2013) Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma. J Clin Endocrinol Metab 98 (1):E119–E125.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets;Frontiers in Endocrinology;2023-01-30

2. Adrenocortical Cancer: A 20-Year Experience of a Single Referral Center in Prognosis and Outcomes;Hormone and Metabolic Research;2021-11

3. The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response;npj Precision Oncology;2021-06-22

4. High Expression of CARM1 Inhibits Lung Cancer Progression by Targeting TP53 by Regulating CTNNB1;Lung;2020-02-07

5. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients;BMC Cancer;2019-11-29